M21 Header Logo

Medical 21’s MedTech Advisory Board

Our MedTech advisory board has a deep and broad base of experience across the fields of cardiac medicine, life sciences, and biomedical engineering. Our highly skilled and knowledgeable group provides crucial expertise that is helping to bring Medical 21’s revolutionary technology to surgeons and patients worldwide.

Meet the MedTech Advisory Board

John Babbit

John Babbit

Partner, Life Sciences at Ernst & Young

John Babbit has 30 years of experience in leadership across all sectors of life sciences, with a focus on medical technology. He has advised both strategic and private equity life science clients. He previously served as the CFO of a publicly-traded medical technology company alongside then-CEO Manny Villafaña. The pair now continue to trailblaze together at Medical 21.

Babbit is a frequent lecturer and guest speaker at prominent life sciences conferences including the Medtech Strategist, the Medtech Conference (AdvaMed), and the BIO Conference. He received his Master of Business Administration from the University of Miami School of Business and attended Ernst & Young’s Executive Leadership Program at Harvard University. He serves on the boards of Children’s HeartLink and the American Heart Association.

Robert Emery Jr

Robert Emery Jr., M.D.

Cardiac Surgeon (Ret.)

Dr. Robert Emery Jr. has decades of experience in the field of cardiovascular surgery. He previously served as the Medical Director of Cardiovascular Surgery at St. Joseph’s Hospital in St. Paul, MN, and at Boston Children’s Hospital. He conducted the initial research on the St. Jude Medical Heart Valve, an innovative mechanical bi-leaflet heart valve that dramatically reduced the frequency of blood clots.

Dr. Emery Jr. received his medical degree from the Tufts School of Medicine. He was a co-founder and First President of the International Society of Minimally Invasive Cardiac Surgery, a member of the American Association for Thoracic Surgery, and a member of the Society of Thoracic Surgeons.

He is a former collegiate gymnast at Penn State University and was named Outstanding Alumni of Penn State in 1996 as well as an Alumni Fellow in 2003.

David Joyce

David Joyce, M.D.

Director of Cardiac Transplantation and Associate Professor, Medical College of Wisconsin

Dr. David Joyce is a valuable member of the Cardiac Transplantation department at the Medical College of Wisconsin. He is a former professor at the prestigious Mayo Clinic and a member of the International Society for Heart and Lung Transplant, the Society of Thoracic Surgeons, the American College of Surgeons, the International Society for Minimally Invasive Surgery, the International Society for Heart and Lung Transplant, and the Western Thoracic Surgical Association.

His many awards and honors include:

  • 2011: C. Walton Lillehei/Earl Bakken Prize, Lillehei Surgical Society
  • 2012: TSFRE Scholarship — Leadership program in health policy
  • 2015: “Best of the Best” Syncardia Certified Center, Mayo Clinic
  • 2015: Karis Award for “Living out Mayo Clinic values in an extraordinary way”
  • 2015–2016: Innovation Accelerator Award — Department of Surgery, Mayo Clinic

Dr. Joyce has participated in numerous studies in the field of cardiac surgery. He received his medical degree from Harvard Medical School, completed his residency at Johns Hopkins School of Medicine, his fellowship at Stanford University, and he holds a Master of Business Administration from the University of Chicago. He is the son of Lyle Joyce, M.D., who is also a Medical 21 Partner.

Lyle Joyce

Lyle Joyce, M.D.

Professor of Surgery, Medical College of Wisconsin

World-renowned in the field of cardiothoracic surgery, Dr. Lyle Joyce has practiced medicine for more than 40 years. He focuses on heart transplantation and the surgical treatment of heart failure. Dr. Joyce was a member of the team that implanted the first permanent artificial heart in a man and was the first surgeon to use a total artificial heart in a woman.

His many awards and honors include:

  • 2007: Guide to America’s Top Surgeons, Consumers’ Research Council of America
  • 2011: Socrates Award, Society of Thoracic Surgeons
  • 2011–2012: Best Doctors in America, Best Doctors, Inc
  • 2012: America’s Top Doctors, American Registry, Castle Connolly
  • 2013: American Registry — Castle Connolly Top Doctors, American Academy, LLC
  • 2015: Best Fellows’ Case: 82 year Old Female with Ruptured type II Thoracic Aortic Aneurysm and Arch Aneurysm, International Aortic Summit (IAS) 2015

He is a member of the International Society for Heart and Lung Transplant, the Medical College of Wisconsin, the Society of Thoracic Surgeons, the American College of Surgeons, and has received research grants for and participated in dozens of research projects.

He completed his medical degree at the Baylor College of Medicine and had residencies in general surgery at the University of Minnesota Hospital and Clinic, in cardiothoracic surgery at the University of Utah, and a postdoctoral fellowship in surgery from the University of Minnesota Hospital and Clinic.

Gene Myers

Gene Myers, M.D.

Interventional Cardiologist

Dr. Gene Myers is a Principal at the Florida Institute for Angiography and founder of Gene E. Myers Cardiac/Vascular Consultants. He is credited for discovering cervical precordial angina disease. Dr. Myers has completed more than 20,000 coronary/peripheral procedures.

Dr. Myers received his medical degree from the University of Pennsylvania Medical School, completed cardiology fellowships at Duke University and the University of Georgetown (National Institutes of Health, Children’s National Medical Center), and worked at the Norfolk Regional Medical Center. He served in the United States Navy, achieving the rank of lieutenant commander.

M.L. Suresh Raghavan

M.L. Suresh Raghavan, Ph.D.

Professor of Biomedical Engineering, University of Iowa

Professor Suresh Raghavan has 25 years of experience in cardiopulmonary biomechanics and device design, critical care therapies, soft tissue mechanics, and computational modeling. He is a Fulbright Distinguished Chair. He completed his Ph.D. in bioengineering at the University of Pittsburgh and a fellowship at the American Institute of Medical & Biological Engineering. He has participated in dozens of NIH-funded studies in the field of cardiopulmonary mechanics and diseases and received the University of Iowa’s President and Provost Award for Teaching Excellence in 2020.

Meet the MedTech Advisory Board

Medical 21 Advisory Board Sample Image

John Babbit
Partner, Life Sciences at Ernst & Young

John Babbit

John Babbit

Partner, Life Sciences at Ernst & Young

John Babbit has 30 years of experience in leadership across all sectors of life sciences, with a focus on medical technology. He has advised both strategic and private equity life science clients. He previously served as the CFO of a publicly-traded medical technology company alongside then-CEO Manny Villafaña. The pair now continue to trailblaze together at Medical 21.

Babbit is a frequent lecturer and guest speaker at prominent life sciences conferences including the Medtech Strategist, the Medtech Conference (AdvaMed), and the BIO Conference. He received his Master of Business Administration from the University of Miami School of Business and attended Ernst & Young’s Executive Leadership Program at Harvard University. He serves on the boards of Children’s HeartLink and the American Heart Association.

David Joyce

David Joyce, M.D.

Director of Cardiac Transplantation and Associate Professor, Medical College of Wisconsin

Dr. David Joyce is a valuable member of the Cardiac Transplantation department at the Medical College of Wisconsin. He is a former professor at the prestigious Mayo Clinic and a member of the International Society for Heart and Lung Transplant, the Society of Thoracic Surgeons, the American College of Surgeons, the International Society for Minimally Invasive Surgery, the International Society for Heart and Lung Transplant, and the Western Thoracic Surgical Association.

His many awards and honors include:

  • 2011: C. Walton Lillehei/Earl Bakken Prize, Lillehei Surgical Society
  • 2012: TSFRE Scholarship — Leadership program in health policy
  • 2015: “Best of the Best” Syncardia Certified Center, Mayo Clinic
  • 2015: Karis Award for “Living out Mayo Clinic values in an extraordinary way”
  • 2015–2016: Innovation Accelerator Award — Department of Surgery, Mayo Clinic

Dr. Joyce has participated in numerous studies in the field of cardiac surgery. He received his medical degree from Harvard Medical School, completed his residency at Johns Hopkins School of Medicine, his fellowship at Stanford University, and he holds a Master of Business Administration from the University of Chicago. He is the son of Lyle Joyce, M.D., who is also a Medical 21 Partner.

Gene Myers

Gene Myers, M.D.

Interventional Cardiologist

Dr. Gene Myers is a Principal at the Florida Institute for Angiography and founder of Gene E. Myers Cardiac/Vascular Consultants. He is credited for discovering cervical precordial angina disease. Dr. Myers has completed more than 20,000 coronary/peripheral procedures.

Dr. Myers received his medical degree from the University of Pennsylvania Medical School, completed cardiology fellowships at Duke University and the University of Georgetown (National Institutes of Health, Children’s National Medical Center), and worked at the Norfolk Regional Medical Center. He served in the United States Navy, achieving the rank of lieutenant commander.

Robert Emery Jr

Robert Emery Jr., M.D.

Cardiac Surgeon (Ret.)

Dr. Robert Emery Jr. has decades of experience in the field of cardiovascular surgery. He previously served as the Medical Director of Cardiovascular Surgery at St. Joseph’s Hospital in St. Paul, MN, and at Boston Children’s Hospital. He conducted the initial research on the St. Jude Medical Heart Valve, an innovative mechanical bi-leaflet heart valve that dramatically reduced the frequency of blood clots.

Dr. Emery Jr. received his medical degree from the Tufts School of Medicine. He was a co-founder and First President of the International Society of Minimally Invasive Cardiac Surgery, a member of the American Association for Thoracic Surgery, and a member of the Society of Thoracic Surgeons.

He is a former collegiate gymnast at Penn State University and was named Outstanding Alumni of Penn State in 1996 as well as an Alumni Fellow in 2003.

Lyle Joyce

Lyle Joyce, M.D.

Professor of Surgery, Medical College of Wisconsin

World-renowned in the field of cardiothoracic surgery, Dr. Lyle Joyce has practiced medicine for more than 40 years. He focuses on heart transplantation and the surgical treatment of heart failure. Dr. Joyce was a member of the team that implanted the first permanent artificial heart in a man and was the first surgeon to use a total artificial heart in a woman.

His many awards and honors include:

  • 2007: Guide to America’s Top Surgeons, Consumers’ Research Council of America
  • 2011: Socrates Award, Society of Thoracic Surgeons
  • 2011–2012: Best Doctors in America, Best Doctors, Inc
  • 2012: America’s Top Doctors, American Registry, Castle Connolly
  • 2013: American Registry — Castle Connolly Top Doctors, American Academy, LLC
  • 2015: Best Fellows’ Case: 82 year Old Female with Ruptured type II Thoracic Aortic Aneurysm and Arch Aneurysm, International Aortic Summit (IAS) 2015

He is a member of the International Society for Heart and Lung Transplant, the Medical College of Wisconsin, the Society of Thoracic Surgeons, the American College of Surgeons, and has received research grants for and participated in dozens of research projects.

He completed his medical degree at the Baylor College of Medicine and had residencies in general surgery at the University of Minnesota Hospital and Clinic, in cardiothoracic surgery at the University of Utah, and a postdoctoral fellowship in surgery from the University of Minnesota Hospital and Clinic.

M.L. Suresh Raghavan

M.L. Suresh Raghavan, Ph.D.

Professor of Biomedical Engineering, University of Iowa

Professor Suresh Raghavan has 25 years of experience in cardiopulmonary biomechanics and device design, critical care therapies, soft tissue mechanics, and computational modeling. He is a Fulbright Distinguished Chair. He completed his Ph.D. in bioengineering at the University of Pittsburgh and a fellowship at the American Institute of Medical & Biological Engineering. He has participated in dozens of NIH-funded studies in the field of cardiopulmonary mechanics and diseases and received the University of Iowa’s President and Provost Award for Teaching Excellence in 2020.

Subscribe To Stay Up-to-Date

Please subscribe to learn more about how Medical 21’s advisory board is working to reshape the future of cardiac bypass surgery.

Subscription successful!

This Opportunity is Open to Everyone

Medical 21 is open to investors through Regulation A+ fundraising, which allows accredited investors and the general public alike to participate.

Learn how you can join us in reshaping the future of cardiac bypass surgery.